MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

Search

STERIS PLC

Gesloten

SectorGezondheidszorg

242.43 0.47

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

239.71

Max

242.71

Belangrijke statistieken

By Trading Economics

Inkomsten

32M

178M

Verkoop

-89M

1.4B

K/W

Sectorgemiddelde

36.739

35.739

EPS

2.34

Dividendrendement

0.94

Winstmarge

12.796

Werknemers

17,787

EBITDA

30M

367M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+17.26% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

0.94%

3.08%

Volgende Ex Dividend datum

18 nov 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

1.2B

24B

Vorige openingsprijs

241.96

Vorige sluitingsprijs

242.43

Nieuwssentiment

By Acuity

30%

70%

107 / 371 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Bearish Evidence

STERIS PLC Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

6 aug 2025, 20:30 UTC

Winsten

Steris 1Q Adj EPS $2.34 >STE

6 aug 2025, 20:30 UTC

Winsten

Steris 1Q Rev $1.4B >STE

14 mei 2025, 20:30 UTC

Winsten

Steris Sees FY Adj EPS $9.90-Adj EPS $10.15 >STE

14 mei 2025, 20:30 UTC

Winsten

Steris 4Q Rev $1.5B >STE

14 mei 2025, 20:30 UTC

Winsten

Steris 4Q Adj EPS $2.74 >STE

5 feb 2025, 21:35 UTC

Winsten

Steris: Outlook Does Not Reflect Any Potential Impact From New Tariffs >STE

5 feb 2025, 21:34 UTC

Winsten

Steris: FY25 Guidance Change Is Primarily Due to Currency >STE

5 feb 2025, 21:34 UTC

Winsten

Steris Cuts FY25 Revenue View to Increase of About 6% From Prior View for 6.5%-7%>STE

5 feb 2025, 21:33 UTC

Winsten

Steris 3Q EPS $1.75 >STE

5 feb 2025, 21:30 UTC

Winsten

Steris Sees FY Adj EPS $9.05-Adj EPS $9.15 >STE

5 feb 2025, 21:30 UTC

Winsten

Steris 3Q Rev $1.4B >STE

5 feb 2025, 21:30 UTC

Winsten

Steris 3Q Adj EPS $2.32 >STE

6 nov 2024, 21:41 UTC

Winsten

Steris Backs FY25 Revenue Up 6.5%-7.5% >STE

6 nov 2024, 21:40 UTC

Winsten

Steris 2Q EPS $1.51 >STE

6 nov 2024, 21:30 UTC

Winsten

Steris Sees FY Adj EPS $9.05-Adj EPS $9.25 >STE

6 nov 2024, 21:30 UTC

Winsten

Steris 2Q Adj EPS $2.14 >STE

6 nov 2024, 21:30 UTC

Winsten

Steris 2Q Rev $1.3B >STE

Peer Vergelijking

Prijswijziging

STERIS PLC Prognose

Koersdoel

By TipRanks

17.26% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 283.25 USD  17.26%

Hoogste 295 USD

Laagste 270 USD

Gebaseerd op 5 Wall Street-analisten die 12-maands prijsdoelen bieden voor STERIS PLC - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

5 ratings

4

Buy

1

Hold

0

Sell

Technische score

By Trading Central

225 / 226.35Steun & Weerstand

Korte Termijn

Bearish Evidence

Gemiddeld Termijn

Strong Bullish Evidence

Lange Termijn

Strong Bullish Evidence

Sentiment

By Acuity

107 / 371 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over STERIS PLC

STERIS plc provides infection prevention products and services worldwide. It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.
help-icon Live chat